InsightsStrategy & Competition

Nvidia took 30 years to reach a $1 trillion market value.

By Uttam Dinodia2 min readView this post on LinkedIn

That milestone leaves out the moment it had to abandon the work that was paying its bills.

Early on, Nvidia won a contract to develop graphics technology for a Sega console. Then it realised its technical approach was wrong. According to Jensen Huang's 2023 account, completing the contract would leave Nvidia with an inferior product. Walking away would leave it without the money to survive.

Huang told Sega to find another partner and asked to be paid anyway. Sega agreed, giving Nvidia six months to build the RIVA 128 graphics chip, which he credits with saving the company.

The trillion-dollar milestone came in 2023. The critical early achievement was correcting a mistake before the money ran out.

Nvidia is an exceptional survivor. Its history cannot tell you how long your business should take. It does show how much a milestone leaves out.

A spectacular valuation announcement tells you nothing about whether you are behind.

Company age, founder age and business progress are different measures.

A 2020 study by Pierre Azoulay and colleagues, using US Census data, found that the average age at founding among the fastest-growing 0.1% of new ventures was 45. Relevant industry experience was also associated with higher success rates.

That is evidence against treating youth as a prerequisite. It is no deadline for success, and no proof that waiting helps.

In 1954, Leon Festinger proposed that people turn to social comparisons when objective measures are unavailable. For founders, the practical question is whether the comparison is useful.

Before using another company as your benchmark, check:

  • Stage: Are you solving the same business problem?
  • Conditions: Are the market, funding, and business model comparable?
  • Evidence: What has improved in your customer retention, margins or cash runway over the past year?

Choose measures that fit your stage. Set a target and a review date. A fairer benchmark should still expose weak progress.

"Behind" is a measurement. Choose the ruler before you accept the verdict.

Uttam Dinodia

Uttam Dinodia

Pharmaceutical Business Consultant & Executive Director, A One Afro Limited

Over 22 years in pharmaceutical supply. Helps international manufacturers and Zambian institutions with public tenders, ZAMRA regulatory pathways and distribution.